These data provide a possible mechanistic explanation to the growing body of evidence suggesting a dominant prognostic role of BCL-2 overexpression and a context-dependent role of MYC in DLBCL treated with R-CHOP.18 The gene discussed is BCL2; the disease is diffuse large B-cell lymphoma.